Why there is an IRS.
Open Access
- 1 December 1995
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 96 (6) , 2546
- https://doi.org/10.1172/jci118317
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.Journal of Clinical Investigation, 1995
- Hepatic Nuclear Factor 3- and Hormone-Regulated Expression of the Phosphoenolpyruvate Carboxykinase and Insulin-Like Growth Factor-Binding Protein 1 GenesMolecular and Cellular Biology, 1995
- Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels.1994
- The cyclic adenosine 3',5'-monophosphate- and the glucocorticoid-dependent enhancers are targets for insulin repression of tyrosine aminotransferase gene transcription.Molecular Endocrinology, 1994
- Identification of an insulin-responsive element in the promoter of the human gene for insulin-like growth factor binding protein-1Journal of Biological Chemistry, 1993
- An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.Proceedings of the National Academy of Sciences, 1993
- Regulation of gene expression by insulinBiochemical Journal, 1991
- Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic MiceScience, 1990
- Identification of a Sequence in the PEPCK Gene That Mediates a Negative Effect of Insulin on TranscriptionScience, 1990